Tirzepatide is one molecule that acts on two incretin receptors at once — GIP and GLP-1 — compounded with vitamin B12 and prescribed for weight management alongside diet and exercise. The dual-pathway design is what distinguishes it from a single-receptor medication. A licensed provider reviews every request and prescribes only when treatment is appropriate for you.
Two incretin receptors, one molecule
Tirzepatide is studied at GIP and GLP-1 receptors together — the pathways involved in satiety signaling, gastric emptying, and glucose-dependent insulin release.

